Cell Lysis Market, By Product Type (Instruments and Reagents and Kits), By Cell Type (Mammalian Cells, Microbial Cells and Other Instruments), By Application (Enzyme Engineering, Protein Labelling, Protein-Protein Interaction and Protein Purification), By End User (Academic & Research Institutions, and Pharmaceutical and Biotechnology Companies), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Cell lysis is a first step of fractionation, organelle isolation and protein extraction and purification. Further, the cell lysis has opened many opportunities in proteomics research, which has wide arrange of application in drug discovery and development. Initially the cell lysis was performed by physical methods for cell disruption and extraction of cellular contents. The advancement in technology and research methodology, the reagent-based method came to existence. The most common cell lysis method includes detergents, as they are amphipatic molecules. Further, the reagents and kits differ along with the sample type. For instance, the reagents and kits are different for mammalian, plant, tissue, yeast, and insect protein extraction. Furthermore, the cell lysis has numerous application in point-of-care, molecular diagnostics of pathogens, immunoassays, and cell disruption. The instruments used for cell lysis are also applicable for small scale to large industry scale, which favors the growth of cell lysis market by both the end user i.e. research laboratories and biopharmaceutical industries. The combination of mechanical and non-mechanical methods is expected to further augment the cell lysis market, with evolution in mechanical devices such as sonicator, homogenizer. \Cell Lysis Market accounted for US$ 3.6 Billion 2020 and is estimated to be US$ 7.4 Billion by 2030 and is anticipated to register a CAGR of 7.5%.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Increasing research and development activities in biotechnology and life science industry

The increasing prevalence of cancer and other chronic diseases demands the cell therapy technique for the precise treatment, which in turns favors the growth of cell lysis market. Further, to meet the demand of increasing population the biotechnology industries and biopharmaceutical industries are investing in research and development. For instance, CAR-T cell therapy, in 2017 U.S. Food and Drug Administration approved two CAR-T cell therapy for the treatment of children with acute lymphoblastic leukemia (ALL) and other for the adults with advanced lymphomas. Such more outcome of from research and development supports the growth of cell lysis market.

Furthermore, according the American Cancer Society, in 2017 it was estimated that about 1,688,780 of new cancer cases were expected to be diagnosed. Further, according to World Health Organization (WHO), the cancer accounted for 8.8 Mn of the death worldwide. Such increasing prevalence of cancer demands the extensive research in field of cancer to provide precise treatment.

Cell lysis market is segmented based on product type, cell type, application, end-user and region.

On the basis of Product Type, the global Cell lysis market is segmented into Instruments and Reagents and Kits. Based on Cell Type, the target market is segmented into Mammalian Cells, Microbial Cells and Other Instruments. By Application, the market is segmented into Enzyme Engineering, Protein Labelling, Protein-Protein Interaction and Protein Purification. By End-User, the market is segmented into Academic & Research Institutions, and Pharmaceutical and Biotechnology Companies.

Regional growth engines of the cell culture market

The cell lysis market is expected to be dominated by the North America region followed by Europe and Asia Pacific. The North America dominates the cell culture market owing to increasing presence of biopharmaceutical industries with increasing demand of precision medicine. As in 2015, the president Obama launched a precision medicine initiative in the U.S., which have created awareness regarding precision medicine with their advantages. Further, the Europe is expected to be at second position followed by the North America, due increased research and development within the Europe region, as according to European Federation of Pharmaceutical Industries and Associations, the research and development expenditure in 2016 was US$43,122.4, which supports the cell lysis market in Europe region. 

Further, the Asia Pacific is expected to be the fastest growing region, due to increasing number of chronic disorder demanding the large-scale vaccine production. Further, increasing investment in research and development in China, Japan and Korea is also expected to favor the growth of cell lysis market.

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD Million & CAGR from 2020 – 2030
Market Segmentation	By Product Type- Reagents and Kits and Instruments  By Cell Type-  Mammalian Cells, Microbial Cells and Other Cells By Application- Enzyme Engineering , Protein Labelling, Protein-Protein Interaction and Protein Purification  By End User- Academic & Research Institutions and Pharmaceutical and Biotechnology Companies
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

 

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, the global Cell lysis market is segmented based on product type, cell type, application, end-user and region.

Market Taxonomy for Cell Lysis Market 

By Product Type

• Reagents and Kits

• Instruments 

By Cell Type

• Mammalian Cells

• Microbial Cells 

• Other Cells

By Application

• Enzyme Engineering 

• Protein Labelling

• Protein-Protein Interaction

• Protein Purification 

By End User

• Academic & Research Institutions

• Pharmaceutical and Biotechnology Companies

Next Generation Cancer Diagnostics Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating the cell culture market, include Sigma Aldrich Corporation, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Beckman Coulter, Bio- Rad Laboratories, Cell Signaling Technology, Qiagen N.V., Qsonica, Merck KGaA, and F. Hoffman-La Roche AG.

• Sigma Aldrich Corporation
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Thermo Fisher Scientific, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
•  Becton, Dickinson and Company
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Beckman Coulter
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
•  Bio- Rad Laboratories
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Cell Signaling Technology
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
•  Qiagen N.V.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
•  Qsonica,
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
•  Merck KGaA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• F. Hoffman-La Roche AG.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies